Table 1 Baseline characteristics
Characteristics | No. (%) |
|---|---|
All patients | 11,714 (100) |
Age (years) | |
Median [SE] | 59 [0.1] |
< 65 | 7,784 (66.5) |
≥ 65 | 3,930 (33.5) |
Sex | |
Female | 6,965 (59.5) |
Male | 4,749 (40.5) |
Diabetes mellitus | |
Yes | 2,364 (20.2) |
No | 9,350 (79.8) |
Hypertension | |
Yes | 4,493 (38.4) |
No | 10,521 (61.6) |
Chronic kidney disease | |
Yes | 697 (6.0) |
No | 11,017 (94.0) |
Preexisting antiplatelet agent | |
Yes | 1,267 (10.8) |
No | 10,447 (89.2) |
Body mass index (kg/m2) | |
Median [SE] | 22.9 [0.03] |
< 25.0 | 8,619 (73.6) |
25-29.9 | 2,690 (23.0) |
30-34.9 | 363 (3.1) |
≥ 35.0 | 42 (0.4) |
Platelet count (×103/µL) | |
Median [SE] | 263 [0.6] |
< 350 | 9,410 (80.3) |
≥ 350 | 2,304 (19.7) |
Hemoglobin (g/dL) | |
Median [SE] | 12.4 [0.6] |
< 10 | 1,151 (9.8) |
≥ 10 | 10,563 (90.2) |
Leukocyte count (×103/µL) | |
Median [SE] | 6.7 [0.1] |
< 11 | 10,675 (91.1) |
≥ 11 | 1,039 (8.9) |
Use of high-CAT-risk chemotherapeutics | |
Used | 6,716 (57.3%) |
Not used | 4,998 (42.7%) |